1. Home
  2. BRBR vs ICUI Comparison

BRBR vs ICUI Comparison

Compare BRBR & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BellRing Brands Inc.

BRBR

BellRing Brands Inc.

N/A

Current Price

$16.97

Market Cap

4.0B

ML Signal

N/A

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

N/A

Current Price

$129.50

Market Cap

3.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BRBR
ICUI
Founded
2019
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.9B
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
BRBR
ICUI
Price
$16.97
$129.50
Analyst Decision
Buy
Buy
Analyst Count
16
5
Target Price
$43.56
$182.25
AVG Volume (30 Days)
2.9M
257.3K
Earning Date
05-05-2026
05-22-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
100.62
EPS
0.36
0.03
Revenue
$2,316,600,000.00
$2,231,262,000.00
Revenue This Year
$6.36
N/A
Revenue Next Year
$6.05
$4.46
P/E Ratio
$48.94
$4,459.00
Revenue Growth
16.05
N/A
52 Week Low
$16.05
$107.02
52 Week High
$79.57
$160.29

Technical Indicators

Market Signals
Indicator
BRBR
ICUI
Relative Strength Index (RSI) 34.98 29.89
Support Level N/A $121.49
Resistance Level $19.35 $136.39
Average True Range (ATR) 0.97 5.64
MACD 0.17 -2.05
Stochastic Oscillator 22.38 10.90

Price Performance

Historical Comparison
BRBR
ICUI

About BRBR BellRing Brands Inc.

BellRing Brands Inc is a United States-based company engaged in providing nutrition-related products. Its brands, Premier Protein, Dymatize, and PowerBar provides various products including ready-to-drink protein shakes, powders and nutrition bars. The company's products are distributed through a diverse network of channel including club, food, drug and mass, eCommerce, convenience and specialty.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

Share on Social Networks: